B19 Parvovirus Withstands “Super Heating” in Antihemophilic Concentrates

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Thromb Haemost 1996; 76(05): 821
DOI: 10.1055/s-0038-1650672

Letters to the Editor

Schattauer GmbH Stuttgart

M Morfini

¹The Hematology Dept, and Hemophilia Center, Azienda Ospedaliera Careggi, Firenze, Italy

,

A Azzi

²The Institute of Microbiology, University of Florence, Italy

,

P M Mannucci

³A. Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital, University of Milan, Italy

Further Information

Received 30 May 1996

Accepted 19 June 1996

Publication Date:
11 July 2018 (online)

References
1 Arrighi S, Rossi R, Borri MG, Lesnikov V, Lesnikova M, Franco E, Divizia M, De Sanctis ME, Bucci E. “In vitro” and in animal model studies on a double virus-inactivated Factor VIII concentrate. Thromb Haemost 1995; 74: 868-873

Thieme Connect PubMed Search in Google Scholar
2 Guillaume T. Parvovirus B19 and blood products. The Lancet 1994; 343: 1101

Crossref PubMed Search in Google Scholar
3 Di Napoli G, Bucci E. Human Parvovirus B19 after concentrates for haemophilia. The Lancet 1994; 343: 1566

PubMed Search in Google Scholar
4 Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M. Eliminating parvovirus B19 from blood products. The Lancet 1994; 343: 798

PubMed Search in Google Scholar